These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12615511)

  • 1. The potential efficacy of thalidomide in the treatment of recalcitrant alopecia areata.
    Namazi MR
    Med Hypotheses; 2003 Apr; 60(4):513-4. PubMed ID: 12615511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatment for alopecia areata.
    Otberg N
    Dermatol Ther; 2011; 24(3):320-5. PubMed ID: 21689241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Changing Landscape of Alopecia Areata: An Introduction.
    Han G
    Adv Ther; 2017 Jul; 34(7):1584-1585. PubMed ID: 28646391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alopecia areata: update on therapy].
    Assouly P
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):831-6. PubMed ID: 12223967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata.
    Sakakibara M; Shimoyama H; Nomura M; Nakashima C; Hirabayashi M; Sei Y; Kuwano Y
    Eur J Dermatol; 2019 Aug; 29(4):436-437. PubMed ID: 31625923
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil in extensive Alopecia areata: no effect in seven patients.
    Köse O; Safali M; Bulent Tastan H; Gur AR
    Dermatology; 2004; 209(1):69-70. PubMed ID: 15237274
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of alopecia areata with apremilast.
    Magdaleno-Tapial J; Valenzuela-Oñate C; Sánchez-Carazo JL; Alegre-de Miquel V
    Australas J Dermatol; 2019 May; 60(2):144-145. PubMed ID: 30294781
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding autoimmunity of vitiligo and alopecia areata.
    Rork JF; Rashighi M; Harris JE
    Curr Opin Pediatr; 2016 Aug; 28(4):463-9. PubMed ID: 27191524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata universalis in a dog.
    Ginel PJ; Blanco B; Pérez-Aranda M; Zafra R; Mozos E
    Vet Dermatol; 2015 Oct; 26(5):379-83, e87. PubMed ID: 26123679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
    Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
    Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
    McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
    J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of efficacy of apremilast in 9 patients with severe alopecia areata.
    Liu LY; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):773-774. PubMed ID: 28917463
    [No Abstract]   [Full Text] [Related]  

  • 14. [A report of successful management with simvastatin plus ezetimibe in alopecia areata].
    Arellano J; Carrasco C; García C
    Medwave; 2020 Nov; 20(9):e8053. PubMed ID: 33231574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study.
    Farshi S; Mansouri P; Safar F; Khiabanloo SR
    Int J Dermatol; 2010 Oct; 49(10):1188-93. PubMed ID: 20883409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of cyclosporin A in patients with severe alopecia areata.
    Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A
    Int J Tissue React; 2005; 27(3):107-10. PubMed ID: 16372476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of alopecia areata: on the cusp and in the future.
    Price VH
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):207-11. PubMed ID: 14582675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfasalazine for alopecia areata.
    Ellis CN; Brown MF; Voorhees JJ
    J Am Acad Dermatol; 2002 Apr; 46(4):541-4. PubMed ID: 11907504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful immunsuppression in childhood alopecia areata.
    Sauerbrey A
    Klin Padiatr; 2011 Jul; 223(4):244-5. PubMed ID: 21509708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.